. 2021 Aug 12;26(4):647–653. doi: 10.5603/RPOR.a2021.0076
© 2021 Greater Poland Cancer Centre
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially
Figure 4.
Final isodose plan after optimization